BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 32999023)

  • 21. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation.
    Moquin SA; Thomas S; Whalen S; Warburton A; Fernandez SG; McBride AA; Pollard KS; Miranda JL
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
    Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus oncoprotein super-enhancers control B cell growth.
    Zhou H; Schmidt SC; Jiang S; Willox B; Bernhardt K; Liang J; Johannsen EC; Kharchenko P; Gewurz BE; Kieff E; Zhao B
    Cell Host Microbe; 2015 Feb; 17(2):205-16. PubMed ID: 25639793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
    Rowe M; Raithatha S; Shannon-Lowe C
    J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
    Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.
    Kanda T; Horikoshi N; Murata T; Kawashima D; Sugimoto A; Narita Y; Kurumizaka H; Tsurumi T
    J Biol Chem; 2013 Aug; 288(33):24189-99. PubMed ID: 23836915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
    J Virol; 2017 May; 91(9):. PubMed ID: 28228591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.
    Chau CM; Lieberman PM
    J Virol; 2004 Nov; 78(22):12308-19. PubMed ID: 15507618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
    Morgan SM; Tanizawa H; Caruso LB; Hulse M; Kossenkov A; Madzo J; Keith K; Tan Y; Boyle S; Lieberman PM; Tempera I
    Nat Commun; 2022 Jan; 13(1):187. PubMed ID: 35039491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatin Structure of Epstein-Barr Virus Latent Episomes.
    Lieberman PM
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):71-102. PubMed ID: 26424644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation of latent Epstein-Barr virus promoters.
    Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
    Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.